| scholarly article | Q13442814 |
| P2093 | author name string | Sato H | |
| Yamada T | |||
| Akiyama Y | |||
| Nagasaki H | |||
| Yuasa Y | |||
| Abe R | |||
| Tsuchiya A | |||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| Lynch syndrome | Q783644 | ||
| P304 | page(s) | 3920-3923 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred | |
| P478 | volume | 57 |
| Q43199969 | A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening |
| Q44095031 | A novel MSH2 germline mutation in a Druze HNPCC family |
| Q79858923 | A novel MSH2 mutation in a Chinese family with hereditary non-polyposis colorectal cancer |
| Q33269177 | A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer |
| Q28283356 | A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer |
| Q35013990 | A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory |
| Q35934041 | A636P testing in Ashkenazi Jews |
| Q36416282 | ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes |
| Q35594366 | An insight into the genetic pathway of adenocarcinoma of the small intestine |
| Q38202510 | Architecture of inherited susceptibility to colorectal cancer: a voyage of discovery |
| Q36309767 | Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection |
| Q37686215 | Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer |
| Q35597362 | Association between family history and mismatch repair in colorectal cancer |
| Q24539206 | Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. |
| Q35566035 | Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? |
| Q36693771 | Chemotherapeutic implications in microsatellite unstable colorectal cancer |
| Q36065786 | Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma |
| Q37385768 | Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases |
| Q35748966 | Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors |
| Q21328691 | Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients |
| Q39588997 | Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner |
| Q35360590 | DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. |
| Q33947053 | DNA mismatch repair genes and colorectal cancer |
| Q28295863 | DNA replication fidelity and cancer |
| Q37174196 | Detection of hMSH2 and hMLH1 mutations in Chinese hereditary non-polyposis colorectal cancer kindreds |
| Q59159730 | Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility? |
| Q33892398 | Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? |
| Q39297259 | Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group |
| Q37236178 | Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review). |
| Q48317493 | Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers. |
| Q36246478 | Evolution of the nomenclature for the hereditary colorectal cancer syndromes |
| Q36641429 | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
| Q30453984 | Extracolonic manifestations of lynch syndrome |
| Q47149352 | Familial adenomatous polyposis: analysis of genetic instability of microsatellites Loci and genetic alternations of tumor suppressor genes |
| Q39742300 | Flanking sequence specificity determines coding microsatellite heteroduplex and mutation rates with defective DNA mismatch repair (MMR) |
| Q35594265 | Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients |
| Q33739955 | Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions |
| Q33681640 | Genetic implications of double primary cancers of the colorectum and endometrium |
| Q33764029 | Genetic susceptibility to non-polyposis colorectal cancer |
| Q36422099 | Genetic testing for Lynch syndrome: family communication and motivation |
| Q33836026 | Genomic and epigenetic instability in colorectal cancer pathogenesis |
| Q36677899 | Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts |
| Q93493049 | HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management - a Review |
| Q34098053 | Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression |
| Q35355789 | Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis |
| Q34977063 | Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management |
| Q58562100 | Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation |
| Q57729078 | Impact of 226C>T MSH2 gene mutation on cancer phenotypes in two HNPCC-associated highly-consanguineous families from Kuwait: emphasis on premarital genetic testing |
| Q36392688 | Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome |
| Q22003969 | Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer |
| Q35954134 | Is surveillance of the small bowel indicated for Lynch syndrome families? |
| Q62978214 | Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures |
| Q36784982 | Loss of DNA mismatch repair protein hMSH6 in ovarian cancer is histotype-specific |
| Q36246487 | Lynch syndrome genes |
| Q22009114 | MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 |
| Q37620965 | Methods for genome-wide analysis of DNA methylation in intestinal tumors |
| Q31164885 | Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis |
| Q54935980 | Microsatellite instability and frameshift mutations in the Bax gene in hereditary nonpolyposis colorectal carcinoma. |
| Q44201536 | Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer |
| Q35363901 | Microsatellite instability and the clinicopathological features of sporadic colorectal cancer |
| Q64101180 | Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer |
| Q37613569 | Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer |
| Q35129256 | Mismatch repair proficiency and in vitro response to 5-fluorouracil |
| Q33904639 | Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene |
| Q42379696 | Molecular analysis: microsatellity instability and loss of heterozygosity of tumor suppressor gene in hereditary non-polyposis colorectal cancers (HNPCC). |
| Q37360286 | Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant |
| Q25257401 | Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis |
| Q35433209 | Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer |
| Q33378445 | Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair |
| Q81602162 | Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like families |
| Q79198177 | Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer |
| Q55380004 | Nuclear Pedigree Criteria of Suspected HNPCC. |
| Q35829272 | Nuclear localization of human DNA mismatch repair protein exonuclease 1 (hEXO1) |
| Q35765148 | Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+ |
| Q34013141 | Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer |
| Q35022384 | Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers |
| Q36316067 | Report of 16 kindreds and one kindred with hMLH1 germline mutation |
| Q42616545 | Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management |
| Q33722604 | Some aspects of molecular diagnostics in Lynch syndrome |
| Q81400217 | Stage IV early gastric cancer: two cases with microsatellite instability |
| Q37128242 | Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology |
| Q36627936 | The Kub5-Hera/RPRD1B interactome: a novel role in preserving genetic stability by regulating DNA mismatch repair |
| Q28066460 | The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care |
| Q37420429 | The identification of Lynch syndrome in British Columbia |
| Q36615234 | The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers |
| Q35435480 | The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers |
| Q33298821 | Three novel missense germline mutations in different exons of MSH6 gene in Chinese hereditary non-polyposis colorectal cancer families |
| Q35836674 | Tumor microsatellite instability in early onset gastric cancer |
| Q90262857 | Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome |
| Q50785085 | What is the appropriate screening protocol in Lynch syndrome? |
| Q40864619 | hMSH6 deficiency and inactivation of the alphaE-catenin invasion-suppressor gene in HCT-8 colon cancer cells. |
Search more.